CENTER FOR BREAKTHROUGH MEDICINES - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 88981530
Serial Number
88981530
Registration Number
6382057
Word Mark
CENTER FOR BREAKTHROUGH MEDICINES
Status
700 - Registered
Status Date
2021-06-08
Filing Date
2019-12-12
Registration Number
6382057
Registration Date
2021-06-08
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2021-01-12
Attorney Name
Joshua M. Gerben, Esq.
Law Office Assigned Location Code
N60
Employee Name
STEEL, ALYSSA PALADINO
Statements
Disclaimer with Predetermined Text
"CENTER" AND "MEDICINES"
Goods and Services
Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting
Goods and Services
Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research
Classification Information
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2019-12-16
Primary Code
040
First Use Anywhere Date
2021-03-16
First Use In Commerce Date
2021-03-16
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-12-16
Primary Code
042
First Use Anywhere Date
2021-03-16
First Use In Commerce Date
2021-03-16
Current Trademark Owners
Party Name
MORNING LIGHT IP, LLC
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
MORNING LIGHT IP, LLC
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
MORNING LIGHT IP, LLC
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
MORNING LIGHT IP, LLC
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Joshua M. Gerben, Esq.
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship TypeReel Number
Continuity Parent88724623
Trademark Events
Event DateEvent Description
2019-12-16NEW APPLICATION ENTERED IN TRAM
2019-12-16NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2020-03-12ASSIGNED TO EXAMINER
2020-03-16NON-FINAL ACTION WRITTEN
2020-03-16NON-FINAL ACTION E-MAILED
2020-03-16NOTIFICATION OF NON-FINAL ACTION E-MAILED
2020-04-21TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-04-21CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-04-22TEAS/EMAIL CORRESPONDENCE ENTERED
2020-04-22APPROVED FOR PUB - PRINCIPAL REGISTER
2020-04-28ASSIGNED TO LIE
2020-05-12WITHDRAWN FROM PUB - OG REVIEW QUERY
2020-06-26PREVIOUS ALLOWANCE COUNT WITHDRAWN
2020-06-26ASSIGNED TO EXAMINER
2020-06-30NON-FINAL ACTION WRITTEN
2020-06-30NON-FINAL ACTION E-MAILED
2020-06-30NOTIFICATION OF NON-FINAL ACTION E-MAILED
2020-12-07TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-12-07CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-12-07TEAS/EMAIL CORRESPONDENCE ENTERED
2020-12-08APPROVED FOR PUB - PRINCIPAL REGISTER
2020-12-23NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2021-01-12PUBLISHED FOR OPPOSITION
2021-01-12OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2021-03-09NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2021-04-05TEAS REQUEST TO DIVIDE RECEIVED
2021-04-05TEAS STATEMENT OF USE RECEIVED
2021-04-26CASE ASSIGNED TO INTENT TO USE PARALEGAL
2021-04-05DIVISIONAL REQUEST RECEIVED
2021-05-03DIVISIONAL PROCESSING COMPLETE
2021-04-05USE AMENDMENT FILED
2021-05-03STATEMENT OF USE PROCESSING COMPLETE
2021-05-05ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2021-05-06NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2021-06-08REGISTERED-PRINCIPAL REGISTER